Articles from House

  1. Exparel, the $285 painkiller not more effective than $3 older treatment

    The cost of painkillers used by knee surgeons are getting many of their patients bent out of shape!! Two different studies have been conducted on exparel recently and it was found that this so called analgesic, Exparel was no better or effective than an older form of the treatment and as per studies exparel is said to combine bupivacaine, an injectable drug of standard care with a proprietary technique for administering pain relief. But what shocks us is the wholesale cost of a single...
  2. The Viagra Evolution Timeline & Emergence of Generic Viagra

    Sildenafil sold as the brand name Viagra by Pfizer is a pill used to treat erectile dysfunction. This drug was launched in the US in the year 1998 and made it really big with sales over 1.5 billion in in 2016. The bad news for Pfizer is that Viagra’s patent is going to expire in April 2020, resulting in a spike of its generic versions by other manufacturers, giving them very stiff competition in the markets. A deal was negotiated 4 years back that granted Teva Pharmaceuticals USA to start...
  3. Taking Antibiotics For Viral Infections Can Cause Antibiotics Resistance

    CDC reports, “Taking Antibiotics for Viral Infections Can Do More harm than Good” Did anybody realize that popping in antibiotics when you or your little one is suffering from viral infections can cause more harm than good? As per the US Centres for Disease Control and Prevention, where children are concerned, antibiotics prove to be the most usual cause of emergency department visits for adverse drug events. This has been one of the most common messages the CDC has been releasing out this...
  4. Generic Drug Price Fixing is Escalating Costs For Patients

    Claims have been made by 45 states and the Department of Justice that generic drug prices are already fixed and the ostensible conspiracy might have caused U.S. business and customers more than $1 billion. Prosecutors made a complaint that when the drug makers were asked by the pharmacies to give out their lowest prices, then the manufacturers would improvise the bidding process. Michael Cole, head of the antitrust department at the Connecticut attorney general’s office made a statement...
Loading...